Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803

PURPOSE: The purpose of this study was to compare the outcome of patients with intermediate-risk rhabdomyosarcoma (RMS) treated with standard VAC (vincristine, dactinomycin, and cyclophosphamide) chemotherapy to that of patients treated with VAC alternating with vincristine, topotecan, and cyclophos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Arndt, Carola A.S., Stoner, Julie A., Hawkins, Douglas S., Rodeberg, David A., Hayes-Jordan, Andrea A., Paidas, Charles N., Parham, David M., Teot, Lisa A., Wharam, Moody D., Breneman, John C., Donaldson, Sarah S., Anderson, James R., Meyer, William H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2773476/
https://ncbi.nlm.nih.gov/pubmed/19770373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.3768
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados